A “nema” of hope in the treatment of late-onset nemaline myopathy
- 12 August 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 71 (7), 472-473
- https://doi.org/10.1212/01.wnl.0000324861.44410.be
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- SPORADIC LATE-ONSET NEMALINE MYOPATHY EFFECTIVELY TREATED BY MELPHALAN AND STEM CELL TRANSPLANTNeurology, 2008
- STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHYNeurology, 2008
- Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscleBrain, 2008
- High-Dose Melphalan versus Melphalan plus Dexamethasone for AL AmyloidosisThe New England Journal of Medicine, 2007
- Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variantsAnnals of Neurology, 2007
- Adult-Onset Nemaline Myopathy and Monoclonal GammopathyArchives of Neurology, 2006
- Sporadic late onset nemaline myopathyNeurology, 2005
- Molecular classification of nemaline myopathies: “nontyping” specimens exhibit unique patterns of gene expressionNeurobiology of Disease, 2004
- Molecular Immunology and Genetics of Inflammatory Muscle DiseasesArchives of Neurology, 1998
- Progressive Nemaline (Rod) Myopathy Associated with HIV InfectionThe New England Journal of Medicine, 1987